Sponsor of the Day:
Jerkmate
https://www.medtechdive.com/news/insulet-competitive-conversions-omnipod-5/625177/
Insulet targets competitive conversions as Omnipod 5 insulin pump nears full launch | MedTech Dive
The company said at a conference it aims to increase the rate of insulin pump use among people with Type 1 diabetes in the U.S.
launch medtech diveomnipod 5insulin pumpinsulettargets
https://www.statnews.com/2024/12/05/insulet-wins-trade-secret-case-against-eoflow-insulin-pump-maker/
Insulet wins trade secrets case against Korean competitor EOFlow
Dec 6, 2024 - Insulin pump maker Insulet won $452 million in its trade secret case against Korean rival EOFlow, which Medtronic was looking to acquire in 2023.
trade secrets caseinsuletwinskoreancompetitor
https://www.insulet.com/
Home | Insulet
insulet
https://www.insulet.com/news-and-stories
News & Stories | Insulet
news storiesinsulet
https://www.medtechdive.com/news/tandem-gets-fda-ok-for-first-interoperable-insulin-pump/548551/
Insulet gains 'ACE' label for interoperable insulin pump, following Tandem | MedTech Dive
Sep 23, 2019 - Diabetes tech company Insulet said Monday FDA granted its commercialized Omnipod Dash system clearance as an alternate controller enabled infusion pump.
insulin pumpmedtech diveinsuletgainsace
https://www.insulet.com/anniversary
25th Anniversary | Insulet
25th anniversaryinsulet
https://www.insulet.com/about-insulet
About Insulet | Insulet
insulet
https://www.insulet.com/our-impact/sustainable-product-innovation
Sustainable product innovation | Insulet
sustainable productinnovationinsulet
https://www.medtechdive.com/news/insulet-eoflow-jury-verdict-patent-lawsuit/734745/
Insulet awarded $452M in EOFlow patent fight | MedTech Dive
A jury found that competitor EOFlow and former executives misappropriated trade secrets for Insulet’s Omnipod insulin pumps.
medtech diveinsuletawardedpatentfight